Open AccessA espessura do músculo adutor do polegar não está associada a Proteína C Reativa em pacientes com câncer hospitalizados
Author(s) -
Nathália da Cunha Ferré,
Rebeca Palhares Barbosa,
Thaís C. Borges,
Gustavo D. Pimentel
Publication year - 2021
Publication title -
braspen journal
Language(s) - English
Resource type - Journals
eISSN - 2764-1546
pISSN - 2525-7374
DOI - 10.37111/braspenj.2020354003
Subject(s) - adductor pollicis muscle , medicine , body mass index , adductor muscles , logistic regression , gastroenterology , surgery , anatomy , elbow , ulnar nerve
Objective: To evaluate the association between blood of C-reactive protein concentrations andan indicator of muscle mass in hospitalized cancer patients. Methods: A cross-sectional studycarried out with 110 patients of both sexes, aged ≥18 years, with solid and/or liquid cancerundergoing clinical and/or surgical treatment. Clinical and socioeconomic data were obtainedfrom medical records. The adductor pollicis muscle thickness was obtained using skinfold caliper.Patients were divided into two groups: altered adductor pollicis muscle thickness (<13.4 mm)and normal adductor pollicis muscle thickness (≥13.4 mm). Logistic regression was performed toverify the association between adductor pollicis muscle thickness and C-reactive protein. Results:It was observed that 90% (n = 100) of the patients were classified with reduced adductor pollicismuscle thickness, higher prevalence of the solid tumor, low usual weight, current weight, andbody mass index. The logistic regression analysis showed no association between the adductorpollicis muscle thickness and C-reactive protein concentrations, in any of models used: modelwithout adjustment (OR: 1.01; 95% CI [0.94-1.09], p = 0.65); adjusted for sex and age (OR: 1.01;95% CI [0.94-1.09], p = 0.61); and adjusted model for sex, age and body mass index (BMI) (OR:1.04; 95% CI [0.96-1.13], p = 0.29). Conclusion: Although adductor pollicis muscle thickness isvalidated method for nutritional assessment, we did not find an association with the inflammationmarker (C-reactive protein).